Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Osprey secures financing to advance OPL-CCL2-LPM into clinic

Feb. 5, 2007

Phase IIb study begins for ozarelix in BPH

Jan. 29, 2007

Fresenius seeks approval for PhosLo in patients with Stage 4 chronic kidney disease

Jan. 25, 2007

Recent Janssen and Aska patents report new therapeutic agents for urological disorders

Jan. 23, 2007

MN-001 shows no statistically significant improvement in interstitial cystitis

Jan. 19, 2007

Silodosin shows positive effects in BPH

Jan. 18, 2007

Phase III program under way for cetrorelix in BPH

Jan. 12, 2007

New vitamin D3 receptor agonists prepared and tested at Chugai

Jan. 10, 2007

Shionogi and Nippon Kayaku end Japanese development agreement for NS-75B

Jan. 9, 2007

Tengion studies urinary neobladder construct in phase II

Jan. 9, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...